Skip to main content
Top
Published in: Supportive Care in Cancer 2/2013

01-02-2013 | Original Article

Unplanned presentations of cancer outpatients: a retrospective cohort study

Authors: G. Aprile, F. E. Pisa, A. Follador, L. Foltran, F. De Pauli, M. Mazzer, S. Lutrino, C. S. Sacco, M. Mansutti, G. Fasola

Published in: Supportive Care in Cancer | Issue 2/2013

Login to get access

Abstract

Purpose

As a result of the growing cancer incidence and the increasing trend towards chemotherapy treatment, a higher number of cancer outpatients ask for unplanned visits. This study aimed to describe the nature and magnitude of this phenomenon and to identify risk factors for repeated unplanned presentations and hospital admission.

Methods

Unplanned consultations (2,811) of 1,431 cancer patients who accessed our acute oncology clinic over a 2-year period were reviewed. Demographics, clinical variables and reason(s) for presentation were all recorded. Recurrent event survival analysis was used to evaluate the relation of potential predictors to the two outcome events repeated presentations and hospitalization. A stratified Cox proportional hazard model was used.

Results

Of 1,431 patients, 625 (43 %) received chemotherapy during the 90 days before the unplanned visit. Pain (27.7 %), fatigue (17.6 %), dyspnoea (13.8 %), fever (11.5 %) and gastrointestinal problems (31 %) were reported frequently. The time interval since the last chemotherapy was significantly related to the rate of repeated presentation. Two hundred and nine patients (7 %) were hospitalized after an unplanned presentation. Number of symptoms and selected toxicities, along with distance from the hospital, were all predictors for hospitalization.

Conclusions

The management of unscheduled presentations of cancer outpatients is becoming crucial to avoid inappropriate selection for hospital admission and interferences with the ordinary work plan, improving quality of oncology services.
Literature
1.
go back to reference Berrino F, De Angelis R, Sant M et al (2007) Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 8:773–783PubMedCrossRef Berrino F, De Angelis R, Sant M et al (2007) Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 8:773–783PubMedCrossRef
2.
go back to reference De Angelis R, Grande E, Inghelmann R et al (2007) Cancer prevalence estimates in Italy from 1970 to 2010. Tumori 93:392–397PubMed De Angelis R, Grande E, Inghelmann R et al (2007) Cancer prevalence estimates in Italy from 1970 to 2010. Tumori 93:392–397PubMed
3.
go back to reference McKenzie H, Hayes L, White K et al (2011) Chemotherapy outpatients' unplanned presentations to hospital: a retrospective study. Support Care Cancer 19:963–969PubMedCrossRef McKenzie H, Hayes L, White K et al (2011) Chemotherapy outpatients' unplanned presentations to hospital: a retrospective study. Support Care Cancer 19:963–969PubMedCrossRef
4.
go back to reference Mayer DK, Travers D, Wyss A, Leak A, Waller A (2011) Why do patients with cancer visit emergency departments? Results of a 2008 population study in North Carolina. J Clin Oncol 29:2683–2688PubMedCrossRef Mayer DK, Travers D, Wyss A, Leak A, Waller A (2011) Why do patients with cancer visit emergency departments? Results of a 2008 population study in North Carolina. J Clin Oncol 29:2683–2688PubMedCrossRef
5.
go back to reference Diaz-Couselo FA, O'Connor JM, Nervo A et al (2004) Nonscheduled consultation in oncologic patients. How many of them are true emergencies? An observational prospective study. Support Care Cancer 12:274–277PubMedCrossRef Diaz-Couselo FA, O'Connor JM, Nervo A et al (2004) Nonscheduled consultation in oncologic patients. How many of them are true emergencies? An observational prospective study. Support Care Cancer 12:274–277PubMedCrossRef
6.
go back to reference Aprile G, Ramoni M, Keefe D, Sonis S (2009) Links between regimen-related toxicities in patients being treated for colorectal cancer. Curr Opin Support Palliat Care 3:50–54PubMedCrossRef Aprile G, Ramoni M, Keefe D, Sonis S (2009) Links between regimen-related toxicities in patients being treated for colorectal cancer. Curr Opin Support Palliat Care 3:50–54PubMedCrossRef
7.
go back to reference Cheung WJ, Le LW, Zimmermann C (2009) Symptom clusters in patients with advanced cancers. Support Care Cancer 17:1223–1230PubMedCrossRef Cheung WJ, Le LW, Zimmermann C (2009) Symptom clusters in patients with advanced cancers. Support Care Cancer 17:1223–1230PubMedCrossRef
8.
go back to reference Bang SM, Park SH, Kang HG et al (2005) Changes in quality of life during palliative chemotherapy for solid cancer. Support Care Cancer 13:515–521PubMedCrossRef Bang SM, Park SH, Kang HG et al (2005) Changes in quality of life during palliative chemotherapy for solid cancer. Support Care Cancer 13:515–521PubMedCrossRef
9.
go back to reference Hovan AJ, Williams PM, Stevenson-Moore P et al (2010) A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer 18:1081–1087PubMedCrossRef Hovan AJ, Williams PM, Stevenson-Moore P et al (2010) A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer 18:1081–1087PubMedCrossRef
10.
go back to reference Pinto C, Barone CA, Girolomoni G et al (2011) Management of skin toxicity associated with cetuximab treatment in combination with chemotherapy or radiotherapy. Oncologist 16:228–238PubMedCrossRef Pinto C, Barone CA, Girolomoni G et al (2011) Management of skin toxicity associated with cetuximab treatment in combination with chemotherapy or radiotherapy. Oncologist 16:228–238PubMedCrossRef
11.
go back to reference Bennett CL, Calhoun EA (2007) Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients. Oncologist 12:478–483PubMedCrossRef Bennett CL, Calhoun EA (2007) Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients. Oncologist 12:478–483PubMedCrossRef
12.
go back to reference Calhoun EA, Chang CH, Welshman EE, Fishman DA, Lurain JR, Bennett CL (2001) Evaluating the total costs of chemotherapy-induced toxicity: results from a pilot study with ovarian cancer patients. Oncologist 6:441–445PubMedCrossRef Calhoun EA, Chang CH, Welshman EE, Fishman DA, Lurain JR, Bennett CL (2001) Evaluating the total costs of chemotherapy-induced toxicity: results from a pilot study with ovarian cancer patients. Oncologist 6:441–445PubMedCrossRef
13.
go back to reference Hassett MJ, O'Malley AJ, Pakes JR, Newhouse JP, Earle CC (2006) Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer. J Natl Cancer Inst 98:1108–1117PubMedCrossRef Hassett MJ, O'Malley AJ, Pakes JR, Newhouse JP, Earle CC (2006) Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer. J Natl Cancer Inst 98:1108–1117PubMedCrossRef
14.
go back to reference Wagner-Johnston ND, Carson KA, Grossman SA (2010) High outpatient pain intensity scores predict impending hospital admissions in patients with cancer. J Pain Symptom Manage 39:180–185PubMedCrossRef Wagner-Johnston ND, Carson KA, Grossman SA (2010) High outpatient pain intensity scores predict impending hospital admissions in patients with cancer. J Pain Symptom Manage 39:180–185PubMedCrossRef
15.
go back to reference Hernandez C, Jansa M, Vidal M et al (2009) The burden of chronic disorders on hospital admissions prompts the need for new modalities of care: a cross-sectional analysis in a tertiary hospital. QJM 102:193–202PubMedCrossRef Hernandez C, Jansa M, Vidal M et al (2009) The burden of chronic disorders on hospital admissions prompts the need for new modalities of care: a cross-sectional analysis in a tertiary hospital. QJM 102:193–202PubMedCrossRef
16.
go back to reference Elting LS, Lu C, Escalante CP et al (2008) Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia. J Clin Oncol 26:606–611PubMedCrossRef Elting LS, Lu C, Escalante CP et al (2008) Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia. J Clin Oncol 26:606–611PubMedCrossRef
17.
go back to reference Whitmer KM, Pruemer JS, Nahleh ZA, Jazieh AR (2006) Symptom management needs of oncology outpatients. J Palliat Med 9:628–630PubMedCrossRef Whitmer KM, Pruemer JS, Nahleh ZA, Jazieh AR (2006) Symptom management needs of oncology outpatients. J Palliat Med 9:628–630PubMedCrossRef
18.
19.
go back to reference Prentice RL, Williams BJ, Peterson AV (1981) On the regression analysis of multivariate failure time data. Biometrika 68:373–379CrossRef Prentice RL, Williams BJ, Peterson AV (1981) On the regression analysis of multivariate failure time data. Biometrika 68:373–379CrossRef
20.
go back to reference Serraino D, Bidoli E, De Paoli A, De Dottori M, Zucchetto A, Zanier L (2009) Cancer in Friuli Venezia Giulia. Incidence, survival and prevalence: 1995-2005. Registro tumori del Friuli Venezia Giulia. Litho Stampa, Udine Serraino D, Bidoli E, De Paoli A, De Dottori M, Zucchetto A, Zanier L (2009) Cancer in Friuli Venezia Giulia. Incidence, survival and prevalence: 1995-2005. Registro tumori del Friuli Venezia Giulia. Litho Stampa, Udine
21.
go back to reference Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA (2009) Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 27:2758–2765PubMedCrossRef Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA (2009) Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 27:2758–2765PubMedCrossRef
22.
go back to reference Peppercorn JM, Weeks JC, Cook EF, Joffe S (2004) Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review. Lancet 363:263–270PubMedCrossRef Peppercorn JM, Weeks JC, Cook EF, Joffe S (2004) Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review. Lancet 363:263–270PubMedCrossRef
23.
go back to reference Ioannidis JP, Lau J (2001) Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. JAMA 285:437–443PubMedCrossRef Ioannidis JP, Lau J (2001) Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. JAMA 285:437–443PubMedCrossRef
24.
go back to reference Goudas LC, Bloch R, Gialeli-Goudas M, Lau J, Carr DB (2005) The epidemiology of cancer pain. Cancer Invest 23:182–190PubMedCrossRef Goudas LC, Bloch R, Gialeli-Goudas M, Lau J, Carr DB (2005) The epidemiology of cancer pain. Cancer Invest 23:182–190PubMedCrossRef
25.
go back to reference Storey DJ, Waters RA, Hibberd CJ et al (2007) Clinically relevant fatigue in cancer outpatients: the Edinburgh Cancer Centre symptom study. Ann Oncol 18:1861–1869PubMedCrossRef Storey DJ, Waters RA, Hibberd CJ et al (2007) Clinically relevant fatigue in cancer outpatients: the Edinburgh Cancer Centre symptom study. Ann Oncol 18:1861–1869PubMedCrossRef
27.
go back to reference Kleeberg UR, Tews JT, Ruprecht T, Hoing M, Kuhlmann A, Runge C (2005) Patient satisfaction and quality of life in cancer outpatients: results of the PASQOC study. Support Care Cancer 13:303–310PubMedCrossRef Kleeberg UR, Tews JT, Ruprecht T, Hoing M, Kuhlmann A, Runge C (2005) Patient satisfaction and quality of life in cancer outpatients: results of the PASQOC study. Support Care Cancer 13:303–310PubMedCrossRef
28.
go back to reference Hassett MJ, Rao SR, Brozovic S et al (2011) Chemotherapy-related hospitalization among community cancer center patients. Oncologist 16:378–387PubMedCrossRef Hassett MJ, Rao SR, Brozovic S et al (2011) Chemotherapy-related hospitalization among community cancer center patients. Oncologist 16:378–387PubMedCrossRef
29.
go back to reference Uramoto H, Iwashige A, Kagami S, Tsukada J (2007) Prediction of emergency hospitalization of outpatients receiving cancer chemotherapy. Anticancer Res 27:1133–1136PubMed Uramoto H, Iwashige A, Kagami S, Tsukada J (2007) Prediction of emergency hospitalization of outpatients receiving cancer chemotherapy. Anticancer Res 27:1133–1136PubMed
Metadata
Title
Unplanned presentations of cancer outpatients: a retrospective cohort study
Authors
G. Aprile
F. E. Pisa
A. Follador
L. Foltran
F. De Pauli
M. Mazzer
S. Lutrino
C. S. Sacco
M. Mansutti
G. Fasola
Publication date
01-02-2013
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 2/2013
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-012-1524-6

Other articles of this Issue 2/2013

Supportive Care in Cancer 2/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine